Past Podcast Episodes

The logistics involved in traveling can be cumbersome, and that's twice as true if you're living with MS. Mobility issues and other special requirements can make travel challenging. But whether you're out exploring the world or just checking into a local hotel for a pampered staycation, travel can add so much to your quality of life. My guest on the podcast is Tarita Davenock. It's been 20 years since Tarita's MS diagnosis. And today, Tarita is the CEO of Travel For All, a travel agency that embraces the philosophy that travel should be inclusive, and not exclusive.

Last week, a federal judge declared the Affordable Care Act to be unconstitutional, and we're talking about what that means for people living with MS. We'll share some newly published results of a stem cell therapy clinical trial, we'll tell you about a study that demonstrates how exercise improves myelin repair in the mouse model of MS, and we'll tell you about CanProCo, a large MS research project just getting underway in Canada.

Jon and RealTalk MS were featured in last week's Causepods podcast. We'll tell you what that's all about, and how Causepods has created a way for you to support the National MS Society.

We have a lot to talk about! Are you ready for RealTalk MS?!

___________

The Affordable Care Act Was Ruled Unconstitutional — What This Means for People Living with MS 2:11

RealTalk MS Is Featured on the CausePods Podcast 6:33

Encouraging Results From Stem Cell Therapy Study, But Questions Still Need To Be Answered 8:18

Ocrevus Approved for Treating Relapsing-Remitting MS in Scotland 10:53

Exercise Promotes Myelin Repair in Mouse Model of MS 12:07

The Canadian Proactive Cohort Study for People Living with MS Will Study 1,000 Canadians Living with MS 14:02

My Interview with Travel For All CEO, Tarita Davenock 16:37

___________

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app
or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

National Patient Groups Denounce District Court Ruling Overturning Health Care Law

Jon Strum & RealTalk MS on the Causepods Podcast

GoFundMe Page Benefiting The National MS Society

Prospective Phase II Clinical Trial of Autologous Hematopoietic Stem Cell Transplant for Treatment Refractory Multiple Sclerosis

Multimodal Enhancement of Remyelination by Exercise with a Pivotal Role for Oligodendroglial PGC1a

Travel For All

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 69
Hosted By: Jon Strum
Guest: Tarita Davenock

Tags: MS, MultipleSclerosis, MS, RealTalkMS, TravelForAll, ACA, ProtectOurCare, MSActivist, HSCT, Ocrevus, CanProCo, MSSocietyCanada, Causepods

Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. My guest is the founder and CEO of iQuity, Dr. Chase Spurlock. iQuity is using its expertise in machine learning to improve patient care, drive the creation of new therapies, and reduce the costs associated with managing chronic illness, including multiple sclerosis.

We're also talking about the important but sometimes overlooked difference between MS facts and MS beliefs. We'll tell you about the safety alert that the FDA has issued for Lemtrada, and new survey research from the MS Society in the UK that shows the majority of people living with MS are living with feelings of loneliness and isolation.

You'll hear about new study data that shows the gender differences in MS have some age-related fine points that are worth noting, and we'll tell you about a Phase 3 clinical trial that's looking at the effectiveness of high-dose biotin in slowing or stopping MS progression for people living with progressive MS.

We have a lot to talk about! Are you ready for RealTalk MS?!

___________

The Difference Between MS Facts & MS Beliefs 0:22

How AI is About to Disrupt Healthcare 4:21

FDA Issues a Safety Alert for Lemtrada 7:40

MS Society in the UK Survey Research Shows 3 in 5 People Living with MS are Living with Loneliness 9:51

Gender Differences in MS Vary with Age & MS Subtype 13:40

MedDay Phase 3 Clinical Trial for Progressive MS Fully Enrolled 15:55

My Interview with iQuity CEO, Dr. Chase Spurlock 17:50

___________

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes
in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

FDA Warns About Rare But Serious Risks of Stroke & Blood Vessel Wall Tears with Multiple Sclerosis Drug Lemtrada

Age-Dependent Variation of Female Preponderance Across Different Phenotypes of Multiple Sclerosis: A Retrospective Cross-Sectional Study

iQuity

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 68
Hosted By: Jon Strum
Guest: Dr. Chase Spurlock

Tags: MS, MultipleSclerosis, MS, RealTalkMS, mssocietyUK, AI, Lemtrada, MedDay, Biotin, iQuity